Repro Med Systems Inc (REPR)

[budge]

"sales to pharmaceutical companies. (.3m?) I think this might be important. "

indeed it is. there are a number of studies that have been started to try and convert drugs that required intra venous administration into forms that can be infused. REPR may be on the cusp of a large increase in their total addressable market.